|
GB202017631D0
|
|
Antivirals
|
|
WO2020070485A1
|
|
Method and apparatus for identifying candidate signatures and compounds for drug therapies
|
|
GB201809050D0
|
|
Modulators of tryptophan catabolism
|
|
EP3532466A1
|
|
Modulators of hedgehog (hh) signalling pathway
|
|
GB201609322D0
|
|
Therapy
|
|
GB201609312D0
|
|
Therapy
|
|
GB201518805D0
|
|
Therapy
|
|
GB201418877D0
|
|
Method and apparatus for identifying candaidate compounds for drug therapies
|
|
US2013296437A1
|
|
Treatment of Depression
|
|
GB201218018D0
|
|
Compounds
|
|
GB201207907D0
|
|
Treatment of depression
|
|
GB201207305D0
|
|
Therapy
|
|
EP2354971A1
|
|
Document analysis system
|
|
GB0915877D0
|
|
Cancer cell apoptosis
|
|
GB0905954D0
|
|
Treatment of exacerbations of asthma
|
|
US2009062136A1
|
|
Identifying components of a network having high importance for network integrity
|
|
GB0813211D0
|
|
Antibacterial combination therapy for the treatment of gram positive bacterial infections
|
|
GB0811024D0
|
|
Sustained release treatment of depression
|
|
GB0808326D0
|
|
Compositions and methods for the treatment of fybromyalgia
|
|
EP2508231A2
|
|
Imidazoles for treating multi-drug resistant bacterial infections
|
